Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin



Status:Recruiting
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:3/27/2019
Start Date:September 26, 2018
End Date:December 2020
Contact:Trial Transparency email recommended (Toll free number for US & Canada)
Email:Contact-US@sanofi.com
Phone:800-633-1610

Use our guide to learn which trials are right for you!

A 56-week, Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly Compared to Dulaglutide Once Weekly in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

Primary Objective:

To demonstrate the noninferiority of once weekly injection of efpeglenatide in comparison to
once weekly injection of dulaglutide on glycated hemoglobin (HbA1c) change in participants
with Type 2 diabetes mellitus (T2DM) inadequately controlled with metformin

Secondary Objectives:

- To demonstrate the superiority of once weekly injection of efpeglenatide with once
weekly injection of dulaglutide on glycemic control

- To demonstrate the superiority of once weekly injection of efpeglenatide with once
weekly injection of dulaglutide on body weight

- To evaluate the safety of once weekly injection of efpeglenatide and once weekly
injection of dulaglutide

Study duration per participant is approximately 65 weeks including an up to 3-week Screening
Period, a 56-week Treatment Period and a 6-week safety Follow-up Period.

Inclusion criteria:

- Participant must be ≥18 years of age at the time of signing the informed consent

- Participants with Type 2 diabetes mellitus (T2DM)

- Diabetes diagnosed at least 1 year before screening

- Participants on stable dose of at least 1500 mg/day of metformin, or tolerated maximum
dose, or as per country regulation if less, for at least 3 months prior to screening

- Glycated hemoglobin (HbA1c) between 7.0% and 10.0% (inclusive) measured by the central
laboratory at screening

Exclusion criteria:

- Retinopathy or maculopathy with one of the following treatments, either recent (within
3 months prior to screening) or planned: intravitreal injections or laser or
vitrectomy surgery

- Clinically relevant history of gastrointestinal (GI) disease associated with prolonged
nausea and vomiting, including (but not limited to) gastroparesis, unstable and not
controlled gastroesophageal reflux disease requiring medical treatment within 6 months
prior to screening or history of surgery affecting gastric emptying

- History of pancreatitis (unless pancreatitis was related to gallstones and
cholecystectomy has been performed), pancreatitis during previous treatment with
incretin therapies, chronic pancreatitis, pancreatectomy

- Personal or family history of medullary thyroid cancer (MTC) or genetic conditions
that predisposes to MTC (e.g., multiple endocrine neoplasia syndromes)

- Body weight change of ≥5 kg within the last 3 months prior to screening

- Systolic blood pressure >180 mmHg and/or diastolic blood pressure >100 mmHg at
randomization

- Severe renal disease as defined by estimated glomerular filtration rate (eGFR, by
Modification of Diet in Renal Disease [MDRD]) of <30 mL/min/1.73 m2

- Laboratory findings at the screening visit:

- Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >3 × ULN or total
bilirubin >1.5 × ULN (except in case of documented Gilbert's syndrome);

- Amylase and/or lipase: >3 x ULN;

- Calcitonin ≥5.9 pmol/L (20 pg/mL)

- Gastric surgery or other gastric procedures intended for weight loss within 2 years
prior to screening, or planned during study period

- Pregnant (confirmed by serum pregnancy test at screening) or breast-feeding women

- Women of childbearing potential (WOCBP) not willing to use highly effective method(s)
of birth control or who are unwilling to be tested for pregnancy during the study
period and for at least 5 weeks after the last dose of study intervention

The above information is not intended to contain all considerations relevant to a patient's
potential participation in a clinical trial.
We found this trial at
27
sites
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
?
mi
from
Bridgeton, NJ
Click here to add this to my saved trials
?
mi
from
Budapest,
Click here to add this to my saved trials
?
mi
from
Chandler, AZ
Click here to add this to my saved trials
Charleston, South Carolina 29412
?
mi
from
Charleston, SC
Click here to add this to my saved trials
?
mi
from
Chula Vista, CA
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Glendale, AZ
Click here to add this to my saved trials
Huntington Park, California 90255
?
mi
from
Huntington Park, CA
Click here to add this to my saved trials
?
mi
from
Layton, UT
Click here to add this to my saved trials
?
mi
from
Lexington, KY
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Manassas, VA
Click here to add this to my saved trials
?
mi
from
Maumee, OH
Click here to add this to my saved trials
?
mi
from
Meridian, ID
Click here to add this to my saved trials
Morehead City, North Carolina 28557
?
mi
from
Morehead City, NC
Click here to add this to my saved trials
?
mi
from
New Windsor, NY
Click here to add this to my saved trials
?
mi
from
Orlando, FL
Click here to add this to my saved trials
?
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
?
mi
from
Peoria, AZ
Click here to add this to my saved trials
?
mi
from
Skokie, IL
Click here to add this to my saved trials
?
mi
from
Snellville, GA
Click here to add this to my saved trials
Spring Valley, California 91978
?
mi
from
Spring Valley, CA
Click here to add this to my saved trials
?
mi
from
Tustin, CA
Click here to add this to my saved trials
?
mi
from
Van Nuys, CA
Click here to add this to my saved trials
?
mi
from
Waterbury, CT
Click here to add this to my saved trials